businesspress24.com - Drugs: Pressemitteilungen - Kategorie - Seite 29
 

Drugs

Category / Pharmaceuticals & Biotech / Drugs


Insys Therapeutics Reports Third Quarter 2014 Financial Results

PHOENIX, AZ: $58.3 Million in Net Revenue Versus $29.2 Million in Q3 2013; Cash, Cash Equivalents, and Investments Up at the End of Quarter to $89.5 Million ...

SciClone Reports Financial Results for the Third Quarter 2014

FOSTER CITY, CA: 2014 EPS Guidance Revised Upward; ZADAXIN(R) Leads Continued Growth of Core Business in 2014 ...

TraceLink Unveils One-Week DSCSA Compliance Solution for Pharmaceutical Supply Chain

WAKEFIELD, MA: Companies Struggling to Develop ASN/Paper Solutions Internally or with 3PL Providers Now Have Streamlined and More Affordable Path to Meet January 1 Deadline ...

Boston Therapeutics Announces the North America Branding of sugardown(R): A New Natural Product That Helps Maintain Healthy Blood Sugar Levels

MANCHESTER, NH: According to CDC, There Are 86 Million People in the U.S. That Have Elevated Blood Glucose Levels; According to the IDF, There Are 382 Million People Worldwide Living With Elevated Blood Sugar and Tha ...

Flamel Technologies Announces Third Quarter Results of Fiscal Year 2014

LYON, FRANCE: Vazculep(TM) Is Now Shipping to Hospitals in All Three Vial Sizes; David Monteith Joins as Vice President, Research and Development; Conference Call With Management to Take Place at 10:00 am ET on Oct ...

Theravance Reports Third Quarter 2014 Financial Results

SOUTH SAN FRANCISCO, CA: William H. Waltrip Appointed Chairman of the Board Effective October 30, 2014; Announces Fourth Quarter Cash Dividend of $0.25 per Share; Theravance to Host Conference Call and Webcast Today at 5:00 p ...


Page 29 von 64:  « ..  28 29 30  31  32  33  34  35  36  37  .. » 64





 

Who is online

All members: 10 563
Register today: 0
Register yesterday: 2
Members online: 0
Guests online: 96


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.